Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Effects of PACAP38 After Glibenclamide
NCT04960657Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Oct 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in migraine comparing PACAP38 + Glibenclamide with PACAP38 + Placebo (2 arms). Primary endpoint: Headache Intensity. Started Oct 2020; status: completed.
02
Drugs
glibenclamide
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04960657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04960657.